SVA vs MSFT: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Microsoft Corp in 2026
SVA
Sinovac Biotech Ltd
$6.47
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | SVA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $642.44M | N/A | SVA |
| P/E Ratio | 6.66 | 26.32 | SVA |
| EPS (TTM) | $0.97 | $15.97 | MSFT |
| Revenue Growth | 3.0% | 0.2% | SVA |
| Gross Margin | 86.8% | 68.6% | SVA |
Analyze SVA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or MSFT a better investment?
Comparing SVA and MSFT: Sinovac Biotech Ltd has a market cap of $642.44M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and MSFT?
SVA (Sinovac Biotech Ltd) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or MSFT?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 26.3x).
Which is growing faster: SVA or MSFT?
SVA has higher revenue growth at 3.0% vs 0.2% for MSFT.
Which company is more profitable: SVA or MSFT?
Sinovac Biotech Ltd (SVA) has higher gross margins at 86.8% compared to 68.6% for MSFT.
Which is the larger company: SVA or MSFT?
Sinovac Biotech Ltd (SVA) is larger with a market cap of $642.44M compared to N/A for MSFT.
Should I buy SVA or MSFT in 2026?
Both SVA and MSFT have investment merit. SVA trades at $6.47 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and MSFT stock?
Key differences: Market Cap ($642.44M vs N/A), P/E Ratio (6.7x vs 26.3x), Revenue Growth (3.0% vs 0.2%), Gross Margin (86.8% vs 68.6%).